5001202025-04-012025-06-305001202025-06-305001202025-04-012025-06-30in-capmkt:OtherExpenses1Member5001202025-04-012025-06-30in-capmkt:ReportableSegments1Member5001202025-04-012025-06-30in-capmkt:ReportableSegments2Member5001202025-04-012025-06-30in-capmkt:ReportableSegments1Member5001202025-04-012025-06-30in-capmkt:ReportableSegments2Member5001202025-04-012025-06-30in-capmkt:ReportableSegments1Member5001202025-06-30in-capmkt:ReportableSegments1Member5001202025-04-012025-06-30in-capmkt:ReportableSegments2Member5001202025-06-30in-capmkt:ReportableSegments2Member5001202025-04-012025-06-30in-capmkt:ReportableSegments1Member5001202025-06-30in-capmkt:ReportableSegments1Member5001202025-04-012025-06-30in-capmkt:ReportableSegments2Member5001202025-06-30in-capmkt:ReportableSegments2Member5001202025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001202025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001202025-06-30Statement15001202025-04-012025-06-30Statement15001202025-06-30StatementDynamic1I1Statement1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500120DIAMINESQNOTLISTEDINE591D01014DIAMINES & CHEMICALS LIMITEDMain BoardEquity2025-04-012026-03-312025-08-122025-08-01INRLakhsQuarterlyFirst quarterMulti segment2025-08-1211:33:002025-08-1213:10:00Not applicabletrue1falseNo default on loan and debt securities2025-04-012025-06-30UnauditedStandalone12229500020476000142771000644660000-80030002580800078000803800078454000168841000-260700000-260700001884000-4056000-21720000-238980000000-238980008978000-149200009784000010-2.44-2.4400-2.44-2.44Other Expenses78454000Speciality Chemicals122295000Trading in Fruits and Vegetables0122295000122295000Speciality Chemicals9814000Trading in Fruits and Vegetables-35806000-2599200078000-26070000Speciality Chemicals1810980000Trading in Fruits and Vegetables0181098000001810980000Speciality Chemicals168783000Trading in Fruits and Vegetables01687830000168783000Gain/(Loss) on measuring equity instruments at Fair Value carried through Other Comprehensive Income (FVTOCI)10595000Remeasurement gain/(loss) on the Defined Benefit Plans-1360001045900014810008978000Preferential Issues2024-10-0150580002025-06-30falsefalseNoneNAHemaxi PawarCompany SecretaryVadodara2025-08-12Capital expenditures, working capital requirements, acquisition, investment in technology and for general corporate purposeNA5058000000Rs.12.51 crs received up to 26.09.2024 (i.e. 25% of the issue). Note: The Company had received In-principle approval for issue not exceeding 916390 number of convertible warrants at Rs. 552 per warrant. The Company had allotted 906390 convertible warrants on receipt of subscription money Rs. 12.51 crores i.e. 25% of the total Issue, on preferential basis to the investors on 01.10.2024.